Advertisement

Innovation

A new drug to treat obsessive-compulsive disorder has become the first compound developed fully by artificial intelligence to enter human clinical trials, the Financial Times reports.

Microsoft on Jan. 29 unveiled AI for Health, a $40 million program that supports the use of artificial intelligence technology to advance medical research and solve global health issues.

Advertisement

Six days before the CDC's Jan. 6 alert of a flulike outbreak in China, and nine days before the World Health Organization's Jan. 9 notice, an artificial intelligence-powered platform had already detected and sent warning of the coronavirus outbreak, Wired…

Clayton Christensen, who coined and defined the concept of disruptive innovation — often named among the most influential business theories of the 21st century — and who regularly applied that theory to the healthcare industry, died Jan. 23, the Deseret…

Advertisement